Management Approach for Abnormal PAPP-A and Free Beta-hCG Levels

Understanding PAPP-A and Free Beta-hCG in Screening

The American College of Medical Genetics recommends that PAPP-A is typically reduced and free beta-hCG is typically elevated in Down syndrome pregnancies, making them valuable first-trimester screening markers 1, 2
The American College of Medical Genetics considers free beta-hCG superior to intact hCG for screening, though many programs in the United States use intact hCG due to limited access to free beta-hCG assays 1, 3
These markers are most effective when combined with nuchal translucency (NT) measurement in first-trimester screening, with detection rates for Down syndrome approximately 70% at a 5% false-positive rate 1, 4

The American College of Obstetricians and Gynecologists considers low PAPP-A (<0.4 MoM) as a major risk factor for fetal growth restriction (FGR) 2
The American College of Obstetricians and Gynecologists recommends implementing increased ultrasound surveillance for fetal growth if PAPP-A <0.4 MoM 2
The American College of Obstetricians and Gynecologists suggests considering low-dose aspirin (75-100 mg daily) starting before 16 weeks' gestation if PAPP-A <0.4 MoM 2

The American College of Medical Genetics recommends that for women presenting early in pregnancy (before 14 weeks), first-trimester screening with NT, PAPP-A, and hCG is an acceptable, cost-effective approach 1, 3
The American College of Medical Genetics considers integrated screening approaches that combine first and second-trimester markers for improved detection rates and lower false-positive rates 1, 5
Options include full integrated test, serum integrated test, and sequential screening, with detection rates ranging from 89% to 92% at 5% false-positive rate 5, 6

The American College of Medical Genetics recommends that an NT measurement ≥3.5 mm warrants detailed anatomic ultrasound and echocardiogram regardless of biochemical marker results or even with normal karyotype 1, 3
The American College of Medical Genetics suggests that women who have first-trimester screening should also be offered maternal serum AFP screening and/or anatomic survey between 16-20 weeks for neural tube defect detection 3, 4
The American College of Medical Genetics notes that sample handling is critical, with PAPP-A and intact hCG stable at 4-8°C for at least 6 days, but free beta-hCG sensitive to high temperatures 7, 8